A Phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignancies
- Elisabeth I. Heath
- , Patricia LoRusso
- , Suresh S. Ramalingam
- , Ahmad Awada
- , Merrill J. Egorin
- , Tatiana Besse-Hamer
- , Fatima Cardoso
- , Manuel Valdivieso
- , Teresa Has
- , Leila Alland
- , Xiaofei Zhou
- , Chandra P. Belani
Research output: Contribution to journal › Article › peer-review
17
Link opens in a new tab
Scopus
citations